Report Highlights
The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.
Report Includes
- 87 data tables and 55 additional tables
- An analysis of the global market for media, sera and reagents in the biotech industry
- Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Evaluation of the overall market size for media, sera and reagents and their corresponding market share analysis by product type, end use and region
- Discussion of the market potential, and forecasts for the market’s segments and sub-segments
- In-depth information concerning market drivers, opportunities, challenges and other demographic and economic factors that will drive demand for media, sera and reagents
- Review of the current market status, key technology issues, industry value chain, Porter’s Five Forces, competitive landscape and R&D activity
- A discussion of the industry’s ESG challenges and practices
- Market share analysis of the key companies in the industry and coverage of their proprietary technologies, strategic alliances, and other market strategies
- Profiles of the leading companies
Report Scope
This report highlights current and future market potential for media, sera and reagents in biotechnology. It provides a detailed analysis of the market drivers, restraints and opportunities. The report includes detailed information on emerging technologies, patent analysis, ESG development, investment outlook and deals. The report also covers market projections through 2029 and presents a competitive landscape. The report provides market estimates and forecasts based on product type, end user and region. The market is segmented by product type into reagents, media and sera. The reagents market is segmented into reagents: biological response modifiers, cell dissociation reagents and others (amino acids, antibiotics, etc.). Market analysis in the media segment is divided into specialty and classical media based on composition. The media are divided into powdered and ready-to-use liquid media based on formulation. Based on serum components, media are segmented into serum-free and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera, including from animal sources such as goats, porcine, rabbits, etc. By end user, the market is segmented into biopharmaceutical companies, academic research institutes, contract research organizations and others. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.
The market is segregated by geographical region into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historical years, 2023 as the base year and 2029 as the forecast year.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||
| Base year market size | $5.9 billion | ||||||||||||||||
| Market size forecast | $9.3 billion | ||||||||||||||||
| Growth rate | CAGR of 8.1% for the forecast period of 2024-2029 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Type, Sub-Type, End User, and Region | ||||||||||||||||
| Regions covered | North America, Asia-Pacific, Europe, and Rest of the World (RoW) | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, and China | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for media, sera and reagents in biotechnology is estimated to grow from $5.0 billion in 2021 to $7.4 billion by 2026 at a compound annual growth rate (CAGR) of 7.9% of during the forecast period of 2021-2026.
Report Highlights
The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.
Report Highlights
The global market for media, sera and reagents used in cell culture will grow from nearly $3.6 billion in 2016 to $4.6 billion by 2021 at a compound annual growth rate (CAGR) of 5.5% between 2016 and 2021.
Report Highlights
The global market for cell culture products will grow from nearly $3.2 billion in 2014 to nearly $4.1 billion by 2019 at a compound annual growth rate (CAGR) of 5.1% between 2014 and 2019.
Report Highlights
The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%.
Report Highlights
- Total worldwide sales revenues for media, sera, and reagent used in the biotechnology were $2,546.2 million in 2010, and are expected to increase to more than $3800 Million in 2015, at a compound annual growth rate (CAGR) of 8.7%.
- The largest biotechnology segments in 2010 were Reagents. All Reagents in Biotechnology will increase from $1,066.6 million in 2010 to nearly $1,850.4 million in 2015, at a compound annual growth rate (CAGR) of 11.6%.
- Sales of Media will experience high growth. This market segment was worth $821.8 million in 2010 and will increase at a 8.6% compound annual growth rate (CAGR) to reach a value of $1,242.4 million in 2015.
- Sales of Sera will experience moderate growth. This market segment was worth $31657.8 million in 2010 and will increase at a 3.3% compound annual growth rate (CAGR) to reach a value of $772.5 million in 2015.
Report Highlights
-
The total U.S. sales of media, sera, and reagents for biotechnology was $979 million in 2005 and almost $1.1 billion in 2006. At a compound annual growth rate (CAGR) of 8.9%, this market will grow to reach more than $1.6 billion in 2011.
-
Sera will grow much more slowly in the market. This particular sector was worth $338.5 million in 2006 and will reach $401 million by 2011, a CAGR of just 3.5%
-
Reagents have the greatest potential for growth, worth $382 million in 2006 and growing at a CAGR of 12.8% to reach almost $700 million by 2011.
Report Highlights
-
The market for media, sera and reagents in U.S. is estimated at $915.6 million in 2003. The market is expected to rise at an AAGR (average annual growth rate) of 13.1% and reach $1.7 billion by 2008.
-
U.S. sales for media are expected to reach $282.3 million in 2003 and $452.5 million in 2008, an AAGR of 9.9%.
-
The sera market, although slow, is rising at an AAGR of 3.5% and will reach $352.1 million in 2008 from $296.0 million in 2003.
-
The reagent market in 2003 is estimated at $337.3 million and is expected to rise at an AAGR of 21.5% and reach $892.6 million by 2008.
-
The reagent segment is the fastest growing, due to increases in expenditures for cell cultures. Ten to 12 new biological response modifiers are coming to market every year.
Report Highlights
-
The U.S. cell culture media market has been growing at a surprisingly fast pace since the last edition of this report, and some of the media suppliers are enjoying a growth rate higher than the overall rate. The U.S. market for cell culture media was estimated to be about $169.5 million in 1999. This is projected to grow to $190.2 million in 2000, and to reach $343.7 million in the year 2005. The estimated average annual growth rate is projected to be about 12.5%.
-
The sera portion of the U.S. market was an estimated $173.9 million in 1999. It should grow to $183.2 million by 2000, and $238.4 million by 2005. The average growth rate is expected to be 5.4% per year throughout this period.
-
The U.S. market for reagents used in cell culture was an estimated $151.7 million in 1999. This should grow to $170.4 million by 2000, and to $315.1 million by 2005. The average growth rate through this period is projected to be 13.0% per year.
Related Reports
Biosimilars: Global Markets
The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.
Global Markets for Enzymes in Industrial Applications
The global market for enzymes in industrial applications is estimated to increase from $7.9 billion in 2024 to reach $10.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.5% from 2024 through 2029.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Recent Reports
Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
The global market for CAR T-cell therapy is expected to grow from $4.6 billion in 2024 and projected to reach $25.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 40.2% from 2024 to 2029.
Therapeutics for Women's Health: Technologies and Global Markets
The global therapeutics for women’s health technologies market is expected to grow from $61.5 billion in 2024 and is projected to reach $81.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024 to 2029.
2024 Protein Synthesis Research Review
Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.
2024 DNA and RNA Synthesis Research Review
The Cell Biology industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years. This report provides a sampling of the types of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.
Top Trending Reports
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
Global Markets for Chemicals for Cosmetics & Toiletries
The global market for chemicals in cosmetics and toiletries is expected to grow from $27.7 billion in 2024 to $35.0 billion by 2029, at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More